Multiple Generics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Generics Today - Breaking & Trending Today

Generic Adderall Shortage Extends to Vyvanse: DEA, Drug Manufacturers Trade Blame

Published: December 8, 2023

As the generic Adderall shortage extends to Vyvanse and Ritalin, DEA and drug manufacturers trade blame for the ADHD medication shortfall.

Source: additudemag.com

Related Topics:

United StatesAnne MilgramSun PharmaSun PharmAmerican Society Of HealthDrug Enforcement AdministrationAssociation For Accessible MedicinesDrug AdministrationNational Community Pharmacists AssociationAccessible MedicinesVyvanse FailsRelieve StimulantAmerican SocietyHealth System PharmacistsMultiple GenericsDhd SymptomsDhd TestDhd MedicationXecutive DysfunctionEjection Sensitive DysphoriaDhd In WomenIgns Of AdhdBipolar DisorderPpositional Defiant DisorderSleep Disorders

Vyvanse Generic Approved by FDA: ADHD Medication Update

Published: September 1, 2023

Vyvanse generic, lisdexamfetamine dimesylate, has received FDA approval, easing cost and accessibility barriers to the ADHD stimulant medication.

Source: additudemag.com

Related Topics:

United StatesWilliam DodsonDrug Enforcement AgencyAmerican Academy Of ChildDrug AdministrationMcgill UniversityBoxed WarningPrescription StimulantsAmerican AcademyAdolescent PsychiatryMultiple GenericsNeuropsychiatr DisDhd SymptomsDhd TestDhd MedicationXecutive DysfunctionEjection Sensitive DysphoriaDhd In WomenIgns Of AdhdBipolar DisorderPpositional Defiant DisorderSleep DisordersEating Disorders